Bioage Labs (BIOA) is scheduled to report Q4 earnings on March 19, 2026. Analysts estimate EPS of $-0.77 and quarterly revenue of $1.14M.
In the most recent quarter (Q3), Bioage Labs reported EPS of $-0.56, beating estimates of $-0.58 by 0.03%. Revenue came in at $2.05M, exceeding the estimate of $777.50K by 1.64%.
Over the last 4 quarters, Bioage Labs has averaged an EPS surprise of 0.24% and a revenue surprise of 2.40%.
Analyze the earnings history of Bioage Labs using advanced sorting and filters.
The chart below shows Bioage Labs's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.56 | $-0.58 | 3.45 % |
| Q2 | 2025-08-06 | $-0.60 | $-0.45 | -33.3 % |
| Q1 | 2025-05-06 | $-0.36 | $-0.53 | 32.1 % |
| Q4 | 2025-03-20 | $-0.59 | $-0.83 | 28.9 % |
The chart below shows Bioage Labs's reported revenue compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $2.05M | $777.50K | 164.2 % |
| Q2 | 2025-08-06 | $2.41M | $580.00K | 315.9 % |
Bioage Labs (BIOA) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
The Actual EPS was $-0.56, which beat the estimate of $-0.58.
The Actual Revenue was $2.05M, which beat the estimate of $777.50K.